A double-blind study of disodium cromoglycate for prophylaxis of bronchial asthma. 1971

J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie

UI MeSH Term Description Entries
D008297 Male Males
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D012075 Remission, Spontaneous A spontaneous diminution or abatement of a disease over time, without formal treatment. Spontaneous Healing,Spontaneous Regression,Spontaneous Remission,Healing, Spontaneous,Regression, Spontaneous,Spontaneous Healings,Spontaneous Regressions
D012129 Respiratory Function Tests Measurement of the various processes involved in the act of respiration: inspiration, expiration, oxygen and carbon dioxide exchange, lung volume and compliance, etc. Lung Function Tests,Pulmonary Function Tests,Function Test, Pulmonary,Function Tests, Pulmonary,Pulmonary Function Test,Test, Pulmonary Function,Tests, Pulmonary Function,Function Test, Lung,Function Test, Respiratory,Function Tests, Lung,Function Tests, Respiratory,Lung Function Test,Respiratory Function Test,Test, Lung Function,Test, Respiratory Function,Tests, Lung Function,Tests, Respiratory Function
D002867 Chromones 1,4-Benzopyrones,Chromone,1,4 Benzopyrones
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D004205 Cromolyn Sodium A chromone complex that acts by inhibiting the release of chemical mediators from sensitized MAST CELLS. It is used in the prophylactic treatment of both allergic and exercise-induced asthma, but does not affect an established asthmatic attack. Disodium Cromoglycate,Sodium Cromoglycate,Aarane,Bicromat Spray,Cromoglicic Acid,Cromoglycate,Cromoglycic Acid,Cromolyn,FPL-670,Intal,Lomudal,Nalcrom,Nasalcrom,Opticrom,Vicrom,Acid, Cromoglicic,Acid, Cromoglycic,Cromoglycate, Disodium,Cromoglycate, Sodium,FPL 670,FPL670
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
January 1973, Acta medica Scandinavica,
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
May 1987, Harefuah,
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
October 1982, British journal of diseases of the chest,
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
October 1971, Canadian Medical Association journal,
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
September 1967, Lancet (London, England),
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
July 1969, British journal of diseases of the chest,
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
October 1971, Arerugi = [Allergy],
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
June 1968, Lancet (London, England),
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
July 1968, Lancet (London, England),
J H Toogood, and N M Lefcoe, and D K Rose, and D R McCourtie
August 1968, Lancet (London, England),
Copied contents to your clipboard!